Calamos Wealth Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
Calamos Wealth Management's BSX.PRA Position: Q2 2023 in Review
Calamos Wealth Management sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 4,570 shares — an estimated $553K sold.
Calamos Wealth Management first reported a position in BSX.PRA in Q2 2020 and held it in 9 quarters. The position peaked at $854K in Q4 2020. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.
- Calamos Wealth Management reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
- Calamos Wealth Management sold 4,570 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $553K.
- Calamos Wealth Management first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 9 quarters.
- Calamos Wealth Management's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $854K in Q4 2020.
- 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.
Based on Calamos Wealth Management's 13F filing for Q2 2023, filed 28 Jul 2023.